DA

Di An

Executive Director, Head Of Biostatistics Rare Diseases at Acadia Pharmaceuticals

Di An is an experienced professional in the field of biostatistics and rare diseases. They have held various leadership roles in biostatistics at companies such as Acadia Pharmaceuticals Inc., Intercept Pharmaceuticals, Gilead Sciences, and Merck & Co., Inc. Di An holds a Ph.D. in Biostatistics from the University of Michigan and a M.S. in Statistics from Texas A&M University.

Links



Teams

This person is not in any teams